Advertisement


Xuesong Han, PhD, on Medicaid Expansion and Receipt of Palliative Care Among Individuals Newly Diagnosed With Advanced-Stage Cancers

2022 ASCO Quality Care Symposium

Advertisement

Xuesong Han, PhD, of the American Cancer Society, discusses findings showing that among newly diagnosed patients with stage IV cancers, Medicaid expansion was associated with increases in receipt of palliative care, although overall usage was low. The increase varied by cancer type. Improving Medicaid coverage may facilitate access to guideline-based palliative care (Abstract 73).



Transcript

Disclaimer: This video transcript has not been proofread or edited and may contain errors.
Palliative care is a guideline based practice for cancer patients with advanced stage. However, the utilization has been low in the United States. In this study, we try to answer this study question whether Medicaid expansion, a major component of the Affordable Care Act, expanding Medicaid eligibility to every adult younger than 65 years with a family income up to 138% Federal poverty level was associated with the receipt of palliative care among cancer patients newly diagnosed with stage IV cancers. To answer this study question, we use the National Cancer Database, a nationwide hospital based cancer registry, capturing 70% of all new cancer cases in the US each year. We identify that our study sample of over 685,000 patients, aged 18 to 64 years, newly diagnosed with first primary stage IV cancers in 2010 through 2019 in 50 states from NCDB. We used a difference in differences approach comparing the changes in receipt of palliative care pre and post ACA in Medicaid expansion states. With the changes in non-expansion states, this indicating a net change associated with Medicaid expansion. Our results show that during the past decade, receipt of palliative care among stage IV cancer patients as part of their first line therapy had increased nationwide. However, the increase was greater in Medicaid expansion states. Specifically, the percent of the stage IV cancer patients who received the palliative care increased from 17% pre ACA to 18.9% post ACA in Medicaid expansion states, and increased from 15.7% to 16.7% in non-expansion states, translating to a net increase of 1.4 percentage points associated with Medicaid expansion. When we stratified by cancer type, we found that the increase was the strongest among the cancers of the lung, colorectal, oral cavity and the [inaudible 00:02:41], Non-Hodgkin's lymphoma, pancreas, and breast cancer among women. These are the most prevalent cancer types at stage IV, and often with a significant symptom burden. In summary, we found that Medicaid expansion was associated with increased receipt of palliative care among patients newly diagnosed with stage IV cancers, although the overall usage remained low. Our findings would suggest that Medicaid expansion can be a policy strategy to improve the guideline based palliative care. Our findings also pointed to a potentially widening geographic disparity in receiving palliative care because of differential state health policies in expanding Medicaid eligibility.

Related Videos

Issues in Oncology

Jensa C. Morris, MD: Oncology Hospitalist Co-Management May Be Linked to Efficient, High-Quality Care and Education

Jensa C. Morris, MD, of the Yale School of Medicine, Smilow Hospitalist Service, discusses her findings on the benefits of hospitalist co-management of patients with cancer: It reduced the length of hospital stay by 1 day, increased early discharge (before 11:00 AM) by threefold; raised the educational rankings of house staff, and lowered oncologists’ stress level, improving their ability to manage competing responsibilities (Abstract 1).

Breast Cancer
Issues in Oncology

Regina Barragán-Carrillo, MD, on Breast Cancer Screening in the Transgender Population

Regina Barragán-Carrillo, MD, of Mexico’s National Institute of Medical Sciences and Nutrition Salvador Zubirán, discusses her findings showing that currently, physicians have limited knowledge about breast cancer screening in transgender patients. Were this topic addressed with widespread information, it could possibly reduce the health-care inequalities faced by this diverse group of patients (Abstract 71).

Issues in Oncology

Joannie M. Ivory, MD, MSPH, on Increasing Participation of Black Patients With Cancer in Clinical Trials

Joannie M. Ivory, MD, MSPH, of The University of North Carolina at Chapel Hill, discusses ways to raise the number of Black patients with cancer who take part in clinical trials. More successful accrual may be linked to conducting trials where Black patients live and designing studies to recruit a concrete target percentage of marginalized populations.

Symptom Management
Issues in Oncology

Dawn L. Hershman, MD, on Prophylactic Colony Stimulating Factors for Neutropenia: Improving Clinicians’ Prescribing Practices

Dawn L. Hershman, MD, of Columbia University College of Physicians and Surgeons, discusses findings that showed substantial variability in clinicians’ adherence to prescribing primary prophylactic colony stimulating factors in a pragmatic trial. Although the ability to opt out of the intervention is a feature of pragmatic trials, careful prestudy planning to estimate nonadherence is critical to ensure adequate power to detect an effect. Understanding reasons for intervention opt-outs may also inform future pragmatic studies aimed at improving adherence to practice guidelines.

Lung Cancer

Qinjin Fan, PhD, on Equitable Lung Cancer Care and Mortgage Discrimination

Qinjin Fan, PhD, of the American Cancer Society, explores the question of how mortgage discrimination is linked to lower rates of guideline-concordant care for patients with non–small cell lung cancer. This study highlights the critical need to understand the pathways through which mortgage denials may negatively affect the receipt of equitable care (Abstract 3).

Advertisement

Advertisement




Advertisement